A fully Cancer Center-managed facility, the Genomics Technologies Shared Resource consists of theMicroarray and Molecular Cytogenetics facilities which provide access to specialized instrumentation andtechnical expertise in high-throughput genomic technologies and molecular cytogenetics for use inindividual and collaborative research programs. Services provided by the facility are: Microarray based genome-wide analysis of gene expression, genetic markers, and DNA copynumber aberrations Microarray based genome-wide analysis of chromatin modifications Validation of microarray and other data by high-throughput quantitative PCR Molecular cytogenetic analysis by fluorescence in situ hybridization (FISH) and spectral karyotyping(SKY) Evaluation and incorporation of emerging genomic technologies and promoting their integration intoresearch programs of HICCC investigators Investigator education and advice in adopting genome wide profiling and molecular cytogenetics intheir cancer research.The microarray component of the Genomics Technologies Shared Resource thus provides acomprehensive set of integrated genomic analysis tools and services that facilitate the high throughputanalysis of genetic and epigenetic alterations in human cancer in basic and translational researchprograms. These services, which are currently focused on procedures with several different microarrayplatforms from Affymetrix and Agilent, with ancillary methods including real-time PCR andPhosphorimaging, are closely linked to those provided by the Biomedical Informatics Shared Resource.The molecular cytogenetics facility provides SKY and FISH characterization of human and mouse tumorcells with efficient turnaround times utilizing state-of-the-art technologies. Together these facilities andservices provide an integrated platform for basic and translational genomics research in cancer biology atthe HICCC. Future plans include evaluating and potentially incorporating an ultra-high-throughputsequencing service into this Resource. During the last period of the CCSG, 53% of the investigators usingthe facility were Cancer Center members with peer-reviewed funding with those members representingfrom 50% to 98% of the usage of the available services. The proposed total operating budget of the facilityis $392,489, of which we are requesting $ 66,831 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-35
Application #
7669916
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-08-01
Project End
2013-06-30
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
35
Fiscal Year
2008
Total Cost
$58,750
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography. Sci Rep 8:13130
O'Neil, Daniel S; Prigerson, Holly G; Mmoledi, Keletso et al. (2018) Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage 56:98-106
Liu, Katherine Y; Sengillo, Jesse D; Velez, Gabriel et al. (2018) Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity. Orphanet J Rare Dis 13:138
Koch, Susanne F; Tsang, Stephen H (2018) Success of Gene Therapy in Late-Stage Treatment. Adv Exp Med Biol 1074:101-107
DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188
Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419
Lee, Andreia; CingĂ–z, Oya; Sabo, Yosef et al. (2018) Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 516:165-175
Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66
Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6
Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451

Showing the most recent 10 out of 331 publications